Furthermore, TF expression has been reported in a number of cancers, such as glioma, pancreatic cancer, non-small-cell lung cancer, colorectal cancer, ovarian cancer, prostate cancer, hepatocellular cancer, and breast cancer [51]. This evidence concerns the gene TF and breast carcinoma.